LivaNova VNS Therapy System, Symmetry, Granted CE Mark for Difficult-to-Treat Depression
LivaNova PLC - Ordinary Shares (LIVN)
Last livanova plc - ordinary shares earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
livanova.com
Company Research
Source: Business Wire
Two UK patients receive innovative VNS Therapy implantable device through new pathway LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Vagus Nerve Stimulation Therapy® (VNS Therapy) System, Symmetry™, earned CE Mark approval for Difficult-to-Treat Depression (DTD). Two patients in the United Kingdom were implanted at the Musgrove Park Hospital in Taunton, England, making them the first patients to receive Symmetry devices outside the United States. The ability to treat these patients with Symmetry was the result of a collaborative effort to develop a VNS Therapy for depression treatment pathway by the Somerset Partnership National Health Service (NHS) Foundation Trust, the Taunton and Somerset NHS Foundation Trust and LivaNova.“With depression affecting so many people in the UK and so many patients suffering from symptoms despite traditional therapy, we were excited to develop a treatment pathway th
Show less
Read more
Impact Snapshot
Event Time:
LIVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIVN alerts
High impacting LivaNova PLC - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
LIVN
News
- Earnings Beat: LivaNova PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models [Yahoo! Finance]Yahoo! Finance
- LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at Mizuho from $80.00 to $70.00. They now have an "outperform" rating on the stock.MarketBeat
- LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $75.00 price target on the stock.MarketBeat
- LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Robert W. Baird from $66.00 to $72.00. They now have an "outperform" rating on the stock.MarketBeat
- LivaNova PLC 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]Seeking Alpha
LIVN
Earnings
- 10/30/24 - Beat
LIVN
Sec Filings
- 11/1/24 - Form 8-K
- 10/31/24 - Form 10-Q
- 10/31/24 - Form IRANNOTICE
- LIVN's page on the SEC website